Concord Drugs Cash Flow Statement

538965 ₹33.45 1.5 4.7%

18/06/21

Speculative, Micro Cap, Contrarian

Market Cap £2.83m

Enterprise Value £3.77m

Revenue £5.43m

Quality

Value

Momentum

StockRank™

To unlock Concord Drugs's cashflow statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	INR	INR	INR	INR	INR	INR

Net Income/Starting Line

Depreciation/Depletion
Non-Cash Items
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Inventories
Other Assets
Accounts Payable
Other Liabilities
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Other Investing Cash Flow Items, Total
Sale of Fixed Assets
Investment, Net
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.